Tade Brad L. 4
4 · ADMA BIOLOGICS, INC. · Filed Nov 22, 2024
Insider Transaction Report
Form 4
Tade Brad L.
CFO and Treasurer
Transactions
- Sale
Common Stock
2024-11-22$21.15/sh−15,000$317,250→ 199,433 total
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") that were granted on June 26, 2023 and vested on June 26, 2024.
- [F2]Includes, as of the transaction date, (i) 72,400 RSUs granted on July 24, 2024, that will vest in four equal installments (25% per installment) on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting;
- [F3](continued from footnote 2) (ii) 56,250 unvested RSUs, granted by the Company on June 26, 2023, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting;
- [F4](continued from footnote 3) (iii) 50,000 RSUs, all of which are currently unvested, granted by the Company on February 26, 2024, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting; and (iv) 20,783 shares acquired in open market purchases and pursuant to the vesting of RSUs.